NextPoint Therapeutics IPO

NextPoint Therapeutics is a biotechnology company specializing in new treatments for patients diagnosed with various forms of cancer. Headquartered in Cambridge, Massachusetts, the company leads fieldwork and clinical development on the novel HHLA2 pathway to deliver a new class of monotherapies for patients who may not benefit from other forms of inhibitors.

Register for Details

For more details on financing and valuation for NextPoint Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about NextPoint Therapeutics

Forge green plus iconForge green minus icon

What is NextPoint Therapeutics's IPO price?

The IPO price for NextPoint Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in NextPoint Therapeutics?

NextPoint Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell NextPoint Therapeutics shares pre-IPO?

If you own NextPoint Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is NextPoint Therapeutics a publicly traded company?

NextPoint Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was NextPoint Therapeutics founded?

NextPoint Therapeutics was founded in 2020.

Who are NextPoint Therapeutics's major investors?

Sanofi Genzyme BioVentures
Invus Group
Leaps by Bayer
Catalio Capital Management
Dana-Farber Cancer Institute
PagodaTree Partners
Sixty Degree Capital
Bluebird Bio
Binney Street Capital
MPM BioImpact
Updated on: Apr 20, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.